Again, they were trying to get market approval which is a high bar without clinical data. Had they started with an more traditional approach (IDE + clinical trials) they could be filing for market approval by now!
The "one day" is coming soon. It is highly unlikely that the IDE will not be approved.
News 
Market Data 
Discover 
AI
